Carmell is developing allogeneic plasma-based biomaterials designed to boost innate regenerative pathways across a variety of skin and bone healing indications. Carmell received FDA clearance for a Phase 2-stage clinical trial designed to study accelerated healing and reduced infections in open tibia (shinbone) fractures with intramedullary rodding and is planning a Phase 2 trial for Foot/Ankle Fusion. Pre-clinical development is also underway in Spinal Fusion, Dental Bone Graft Substitute, Androgenetic Alopecia, Active Soft Tissue Repair, and Cosmetic Skin Rejuvenation. For more information, visit www.carmellrx.com

Manage the accounting, finance, financial reporting, and planning functions for a commercial-stage biopharmaceutical company focused on critical care and ophthalmic productsWork with the executive team and investment bankers to create sophisticated forecasting models used in raising capital and evaluating out-licensing and other business opportunitiesEnsure proper policies and internal controls in place to ensure readiness for IPO or other exit strategiesOversee the month-end close process and present analysis of financial results and key performance metrics to executive leadership and the board of directorsPartner cross-functionally to develop annual budgets, including headcount planning, detailed product development costs, and intercompany allocationsResearch and analyze financial and non-financial data to make recommendations to manage costs and improve financial performanceStreamlined financial reporting, budgeting, and forecasting processes by automating manual processes and leveraging financial system capabilitiesAssisted in the spin-off of operations into two subsidiaries to enhance the company’s ability to raise capital and maximize shareholder value

Assisted in the successful exit to private equity ownership for a mid-size consumer products companyDeveloped financial and cash flow forecasting models to ensure optimal utilization of cash and lines of creditAssisted with the transition of all accounting and financial reporting processes to the new ownership teamOversaw the company’s transaction processing systems to ensure accurate and timely financial reporting

CFO for the North American division of an international commercial facilities service provider with over $250 million in U.S. revenueProvided financial and strategic leadership as a member of the U.S. executive team, including enterprise planning and the development of strategies to drive growth and profitabilityStrategic oversight of accounting, finance, treasury, tax, information systems, and risk management functionsDrove over $1 million in cost savings by creating and staffing a shared service center (50+ professionals) to integrate multiple acquired entities and build a financial platform to support organic and acquisitive growthDecreased time-to-close by over seven days and made significant improvements to financial reporting by developing and implementing standardized accounting policies and procedures Reduced annual IT costs by over $250k by leading a major upgrade of JD Edwards ERP system and integrating acquired entities on a single financial platformImplemented cloud-based travel and expense system to drive cost savings and automate compliance controlsDirected cross-functional teams to leverage technology to reduce manual processes and improve the accuracy and efficiency of finance functionsOversaw the creation of budgets and long-term forecasts to continuously assess financial performance Presented financial results and strategy to the parent company’s management board

Led team of 35+ accounting professionals providing financial management and oversight of EMCOR’s facilities management division with over $500 million in annual revenueDirected all aspects of accounting, including financial reporting and analysis, general ledger accounting, forecasting, budgeting, treasury, accounts payable, accounts receivable, and billingCentralized accounting functions from acquired companies in multiple locations into newly created shared services centers resulting in over $1.5 million in cost savingsDesigned and built out a new organizational structure for all accounting and finance functions to create a scalable organization to facilitate new business growth and provide all levels of staff with clear career pathsRestructured accounts receivable processes to improve cash flow by reducing overdue accounts receivable from over 10% to less than 6% of total receivablesImplemented new revenue recognition (ASC 606) and lease accounting (ASC 842) pronouncementsPartnered with leaders across the business in areas ranging from operations, legal, human resources, business development, and information technology on strategic initiatives and pricingContinuously drove process and systems improvements across the organizationResearched and implemented current and emerging accounting issues and developed accounting policies to ensure compliance with U.S. GAAP and SEC requirementsOversaw the preparation of sales/use tax, income tax, risk management, and other reports and analyses

Directed all aspects of accounting and financial reporting for a private equity-backed technology (SaaS) and health insurance company (No. 20 on Fast Company’s 2013 “World’s Most Innovative Companies”) Built-out accounting and finance functions to support high-growth business (15x revenue growth in 3 years) and ensure readiness for an IPOProvided private-equity partners and senior business leaders with insight into key performance indicators Collaborated with operational leaders to develop detailed budgets and rolling financial and cash flow forecasts Managed the preparation of U.S. GAAP and statutory-basis audited financial statements and regulatory filingsOversaw the monthly close and supervised accounts payable, accounts receivable, and cash management Developed and implemented standardized accounting and compliance policies and procedures, leading to internal control improvements and process efficienciesResearched proposed revenue recognition standard to ensure proper accounting treatment for all customer contracts and worked cross-functionally to formalize a new contract review processImplemented improved forecasting and modeling, resulting in more accurate and timely projections

Led the controllership and finance functions for Nationwide’s investment management division (multiple SEC-registered entities) with over $55 billion in assets under managementManaged the development of complex financial models used for multi-year forecasting and business decision support, including the acquisition of a mutual fund complex with over $3.5 billion of assets under managementLed cross-functional team in the development of comprehensive dashboard reporting of key performance metrics (financial and non-financial), providing senior management with previously unavailable data needed for strategic decision makingSupervised all internal and external financial and regulatory compliance and reporting (SEC and FINRA), including in-depth analyses of financial and operational data and audited financial statementsSupervised the development of forecasts and multi-year strategic plans, partnering with leaders across the businessDeveloped accounting policies and procedures to ensure accurate and efficient reporting of financial data in compliance with U.S. GAAP and SEC regulatory requirementsManaged relationships with internal and independent auditors and regulators

Supervised financial and operational audits and the development of recommendations for internal control and process improvements for a technology-driven clinical research organization (CRO)

Managed all aspects of accounting and financial reporting for international asset management firm with multiple business lines, including mutual funds, institutional asset management, structured financial products, retirement plan administration, and broker-dealer services (over $250 billion in assets under management).

Managed team of seven professionals in the preparation of all financial and management reporting and related analytics, including SEC filings (e.g., Form 10-K, Form 10-Q, and proxy materials), audited financial statements, and regulatory filings for NYSE traded multi-line insurance and financial services company.

Industry specialization in insurance and financial services.